TOXSTA Trademark

Trademark Overview


On Wednesday, June 3, 2020, a trademark application was filed for TOXSTA with the United States Patent and Trademark Office. The USPTO has given the TOXSTA trademark a serial number of 79291052. The federal status of this trademark filing is REGISTERED as of Tuesday, July 27, 2021. This trademark is owned by JETEMA CO., LTD.. The TOXSTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for treating cramps; pharmaceutical preparations for treating muscle; pharmaceutical preparations for treating cerebral palsy; pharmaceutical preparations for treating hyperhidrosis; pharmaceutical agents affecting metabolism; bacteria poisons; Pharmaceutical preparations for treating headache; anaesthetics; pharmaceutical preparations for use in the cosmetic field, namely, medicated cosmetics; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; botulinum toxin for medical use for use in the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for urogenital organs; pharm...
toxsta

General Information


Serial Number79291052
Word MarkTOXSTA
Filing DateWednesday, June 3, 2020
Status700 - REGISTERED
Status DateTuesday, July 27, 2021
Registration Number6430556
Registration DateTuesday, July 27, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 11, 2021

Trademark Statements


Goods and ServicesPharmaceutical agents affecting sensory organs; pharmaceutical preparations for treating cramps; pharmaceutical preparations for treating muscle; pharmaceutical preparations for treating cerebral palsy; pharmaceutical preparations for treating hyperhidrosis; pharmaceutical agents affecting metabolism; bacteria poisons; Pharmaceutical preparations for treating headache; anaesthetics; pharmaceutical preparations for use in the cosmetic field, namely, medicated cosmetics; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; botulinum toxin for medical use for use in the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for urogenital organs; pharmaceutical preparations for plastic surgery; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; veterinary substances and preparations for house pets for injuries and pain, namely, pharmaceuticals containing botulinum toxin; Cardiovascular agents for medical purposes; pharmaceutical preparations for treating neurological disorders; pharmaceutical preparations in the nature of botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives used to treat neurological diseases; Ophthalmic preparations; allergy medications; Chemical preparations for pharmaceutical purposes, namely, for neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; Pharmaceutical agents for epidermis; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; pharmaceutical preparations for skincare in the nature of botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives for medical purposes; pharmaceutical preparations for skin care treatment in the nature of botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives for medical purposes; medicines for human purposes, namely, pharmaceutical preparations for the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; Pharmaceutical preparations for orthopedic purposes; pharmaceutical preparations for treating wrinkles; analgesic preparations; medicines for dental purposes; pharmaceutical preparations for treating pain; pharmaceutical preparation for skin care; medicated preparations for skin treatment; pharmaceutical preparations for respiratory organs; preparations for the treatment of burns; preparations for the treatment of scar
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 7, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJETEMA CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameJETEMA CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameJETEMA CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Friday, October 6, 2023NEW REPRESENTATIVE AT IB RECEIVED
Saturday, January 1, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 13, 2021FINAL DISPOSITION NOTICE SENT TO IB
Monday, December 13, 2021FINAL DISPOSITION PROCESSED
Wednesday, October 27, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 27, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, May 11, 2021NOTIFICATION PROCESSED BY IB
Tuesday, May 11, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 11, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 21, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 21, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 31, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 31, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 31, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 8, 2021NEW REPRESENTATIVE AT IB RECEIVED
Monday, October 19, 2020REFUSAL PROCESSED BY IB
Thursday, October 1, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, October 1, 2020REFUSAL PROCESSED BY MPU
Friday, September 11, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 10, 2020NON-FINAL ACTION WRITTEN
Thursday, September 3, 2020ASSIGNED TO EXAMINER
Tuesday, August 11, 2020APPLICATION FILING RECEIPT MAILED
Friday, August 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 6, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB